Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study

Documenti analoghi

• Effects of trastuzumab emtansine on canine urothelial carcinoma cells in vitro and in vivo
  di: Kosei Sakai, et al.
  Pubblicazione: (2024)
• Prognostic Role of Patient, Tumour and Radiomic Factors Influencing Outcomes in Dogs With Thyroid Cancer Treated With Iodine‐131
  di: Ibrahim Chamseddine, et al.
  Pubblicazione: (2025)
• Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours
  di: Fikriye Ecem Kuruoglu, et al.
  Pubblicazione: (2024)
• Recurrence Rates for Mandibular Fibrosarcoma Associated With Mandibular Canal Invasion Following Mandibulectomy Procedures in Dogs
  di: Carley P. Johnson, et al.
  Pubblicazione: (2026)
• Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma
  di: Kathryn E. Cronise, et al.
  Pubblicazione: (2024)